Evidence map›Paper›PMID 41960073›Full record

ArticleJTCVS open2026

Bronchial sleeve lobectomy with pulmonary artery reconstruction following neoadjuvant chemoimmunotherapy: A propensity score-weighted comparison.

Yuzhou Wang, Yichen Dong, Tao Chen, Jialiang Wen, Long Xu, Jiajun Deng, Yunlang She, Junqi Wu, Qiankun Chen, Lei Jiang and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuzhou WangDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Yichen DongDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Tao ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Jialiang WenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Long XuDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Jiajun DengDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Yunlang SheDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Junqi WuDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Qiankun ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Lei JiangDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Xuefei HuDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Diego Gonzalez-RivasDepartment of Thoracic Surgery and Minimally Invasive Thoracic Surgery Unit, Coruña University Hospital, Coruña, Spain.
Deping ZhaoDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Dong XieDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Chang ChenDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the feasibility and safety of bronchial sleeve lobectomy (BSL) with pulmonary artery reconstruction (PAR) following neoadjuvant chemoimmunotherapy. Methods: Patients undergoing sleeve lobectomy or pneumonectomy after neoadjuvant chemoimmunotherapy between 2019 and 2023 were enrolled in the analysis retrospectively. Perioperative outcomes, overall survival, and event-free survival were compared among the BSL, BSL with PAR, and pneumonectomy (PN) groups before and after propensity score matching weights (MW). Results: In the overall cohort, 143 patients received simple BSL, 49 received BSL with PAR, and 48 underwent PN. There were marked differences in the distribution of age, clinical N stage, and tumor location among the 3 groups. After MW, BSL with PAR was associated with a higher thoracotomy rate ( Conclusions: BSL with PAR can be recognized as a safe and feasible surgical procedure even after neoadjuvant chemoimmunotherapy.

Indexed as

neoadjuvant chemo-immunotherapyperioperative outcomeprognosispulmonary artery reconstructionsleeve lobectomy

Identifiers

PMID41960073
PMCPMC13059959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.